These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 28988743)

  • 21. The Outcome of Unrelated Hematopoietic Stem Cell Transplants with Total Body Irradiation (800 cGy) and Cyclophosphamide (120 mg/kg) in Adult Patients with Acquired Severe Aplastic Anemia.
    Lee JW; Cho BS; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Min WS; Park CW
    Biol Blood Marrow Transplant; 2011 Jan; 17(1):101-8. PubMed ID: 20601037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.
    Behfar M; Koochakzadeh L; Yazdanian N; Salajegheh P; Rostami T; Khodayari-Namini N; Ghavamzadeh A; Hamidieh AA
    Turk J Pediatr; 2019; 61(3):407-412. PubMed ID: 31916719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of a fludarabine-based conditioning regimen in patients with severe aplastic anemia--a retrospective analysis from three Indian centers.
    George B; Mathews V; Lakshmi KM; Melinkeri S; Sharma A; Viswabandya A; Sharma S; Das S; Ahmed R; Abraham A; Nair V; Apte S; Chandy M; Srivastava A
    Clin Transplant; 2013; 27(6):923-9. PubMed ID: 24304374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia.
    Chung NG; Lee JW; Jang PS; Jeong DC; Cho B; Kim HK
    Pediatr Transplant; 2013 Jun; 17(4):387-93. PubMed ID: 23551397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia.
    Arcuri LJ; Nabhan SK; Cunha R; Nichele S; Ribeiro AAF; Fernandes JF; Daudt LE; Rodrigues ALM; Arrais-Rodrigues C; Seber A; Atta EH; de Oliveira JSR; Funke VAM; Loth G; Junior LGD; Paz A; Calixto RF; Gomes AA; Araujo CES; Colturato V; Simoes BP; Hamerschlak N; Flowers ME; Pasquini R; Rocha V; Bonfim C
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2311-2317. PubMed ID: 32949751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
    Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling.
    Mori T; Koh H; Onishi Y; Kako S; Onizuka M; Kanamori H; Ozawa Y; Kato C; Iida H; Suzuki R; Ichinohe T; Kanda Y; Maeda T; Nakao S; Yamazaki H
    Int J Hematol; 2016 Apr; 103(4):461-8. PubMed ID: 26910242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia.
    George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
    Bone Marrow Transplant; 2007 Jul; 40(1):13-8. PubMed ID: 17450183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Antithymocyte Globulin-Free Conditioning Regimen Using Fludarabine and Cyclophosphamide Is Associated with Good Outcomes in Patients Undergoing Matched Related Family Donor Transplantation for Aplastic Anemia.
    George B; Lionel S; Selvarajan S; Abubacker FN; Korula A; Devasia AJ; Kulkarni U; Lakshmi KM; Sindhuvi E; Abraham A; Mathews V
    Transplant Cell Ther; 2021 May; 27(5):409.e1-409.e6. PubMed ID: 33965181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies.
    Iftikhar R; Chaudhry QUN; Anwer F; Neupane K; Rafae A; Mahmood SK; Ghafoor T; Shahbaz N; Khan MA; Khattak TA; Shamshad GU; Rehman J; Farhan M; Khan M; Ansar I; Ashraf R; Marsh J; Satti TM; Ahmed P
    Blood Rev; 2021 May; 47():100772. PubMed ID: 33187812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: A KSGCT prospective study.
    Kako S; Kanda Y; Onizuka M; Aotsuka N; Usuki K; Tachibana T; Kobayashi T; Kato J; Yano S; Shimizu H; Shono K; Tanaka M; Tsukamoto S; Mori T; Yamazaki E; Najima Y; Hangaishi A; Hoshino T; Watanabe R; Matsumoto K; Okamoto S;
    Am J Hematol; 2020 Mar; 95(3):251-257. PubMed ID: 31804748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
    Kröger N; Zabelina T; Renges H; Krüger W; Kordes U; Rischewski J; Schrum J; Horstmann M; Ayuk F; Erttmann R; Kabisch H; Zander AR
    Ann Hematol; 2002 Nov; 81(11):627-31. PubMed ID: 12454700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia.
    Guo Z; Gao HY; Zhang TY; Liu XD; Yang K; Lou JX; He XP; Zhang Y; Chen P; Chen HR
    Int J Hematol; 2016 Dec; 104(6):720-728. PubMed ID: 27709450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning.
    Shin SH; Jeon YW; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Lee JW
    Bone Marrow Transplant; 2016 Nov; 51(11):1456-1463. PubMed ID: 27348538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia.
    Urban C; Benesch M; Sykora KW; Schwinger W; Lackner H
    Bone Marrow Transplant; 2005 Mar; 35(6):591-4. PubMed ID: 15665850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of outpatient fludarabine, cyclophosphamide, and rituximab based allogeneic hematopoietic cell transplantation in adults with severe aplastic anemia.
    Gilmore RM; Abernathy K; Shultes K; Eplin DD; Orton L; Kassim A; Sengsayadeth S; Chinratanalab W; Kim TK; Dholaria B; Jayani RV; Savani BN; McNeer E; Choi L; Gatwood K
    Bone Marrow Transplant; 2024 Sep; 59(9):1275-1279. PubMed ID: 38879608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Single non-blood-related umbilical cord blood transplantation using a reduced-intensity conditioning regimen for the treatment of severe aplastic anemia].
    Wu Y; Tang BL; Song KD; Sun GY; Pan TZ; Huang AJ; Yan BB; Zhu XY
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):68-73. PubMed ID: 38527841
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparative study of porcine antihuman lymphocyte globulin versus antithymocyte globulin-fresenius in an allogeneic hematopoietic cell transplantation conditioning regimen for severe aplastic anemia.
    Zhang Y; Liu L; Si Y; Miao M; Qiu H; Tang X; Han Y; Fu C; Jin Z; Chen S; Sun A; Wu D
    Hematology; 2021 Dec; 26(1):741-750. PubMed ID: 34555301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-Transplant Cyclophosphamide as Sole Graft-versus-Host Disease Prophylaxis Is Feasible in Patients Undergoing Peripheral Blood Stem Cell Transplantation for Severe Aplastic Anemia Using Matched Sibling Donors.
    George B; Pn N; Devasia AJ; Kulkarni U; Korula A; Lakshmi KM; Abraham A; Srivastava A; Mathews V
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):494-500. PubMed ID: 29100905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.